Skip to main content
Top navigation
  • Sustainability reports
  • Focus area: Increase resource efficiency
  • Governance
  • Please fill out this field

Main navigation

    • Our offering
        • Solids & others
            • Manufacturing
                • Solids
                • Semi-solids
                • Liquids
                • Pharmaceutical packaging
                • Controlled drugs
                • High Potent
        • Sterile delivery
            • Manufacturing
                • Sterile vial filling
                • PFS and cartridges
                • Lyophilisation
                • Blow-fill-seal
                • Ampoules
            • Specialised services
                • Ophthalmics
                • Beta-lactams
                • Vaccine manufacturing
        • Advanced Bio
            • Modalities & services
                • xRNA therapies
                • Virus & viral vectros
                • Microbial & live biotherapeutic products
                • Recombinant proteins
            • Continuous manufacturing
            • Innovations & collaborations
        • Additional services
            • ReciPredict
            • Analytical services
            • Regulatory
            • Parenteral drug development
            • New product introduction
                • Technology Transfer
                • Product development
    • Resources
    • About us
        • About us
            • Our leadership
            • Why partner with us
            • Locations
        • Sustainability
            • Sustainability reports
            • Sustainability strategy
            • Net Zero commitment
            • Governance
        • News & Events
            • Press releases
            • Events
    • Careers
        • Careers
            • Who we are
            • Working with us
            • What you can do
            • Job search
    • Contact
Linkedin
Contact
Please fill out this field
No banner Image

Press releases

  • Home
  • About us
  • Press releases
  • Facebook
  • Linkedin
  • Twitter
  • Email

BU-NOT-SET

CONTACT US
December 01 2025
Infant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for commercial production of drug substance
November 26 2025
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support
October 28 2025
Recipharm secures major additional grant to develop AI-enabled manufacturing technologies
October 15 2025
Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON
October 13 2025
Recipharm inaugurates state-of-the-art parenteral development and sterility laboratories
October 08 2025
Recipharm announces Centre of Excellence for Advanced Biologics Analytical Services
September 08 2025
Recipharm partners with NeuroSense Therapeutics to advance ALS therapy PrimeC toward Phase 3 trials
September 02 2025
Recipharm strengthens brand to reinforce customer focus and manufacturing leadership
June 23 2025
Recipharm strengthens BFS leadership with new development contracts, enabling over 90% API savings
June 18 2025
ReciBioPharm celebrates strong first half of 2025 with momentum for the future

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Next page
  • Last page

Footer Webfrom

contact form

Let’s discuss your 
next project

Share your details and start your journey with our global CDMO team.

Stay updated
https://se.linkedin.com/company/recipharm https://www.youtube.com/channel/UCr-bw7pCCkYZfeImOwTfNRg
Footer
  • Privacy policy
  • Cookies
  • Website terms
  • Sitemap
  • Cookie settings
  • Terms & conditions
  • Code of Conduct
© 2025

Recipharm AB. All rights reserved. RECIPHARM® is a registered trademark owned by Recipharm AB.

Delivered by Investisdigital [iDX]